9 Comments
 

I don't think anyone has ever said EB Rx is the best starting place for L/S equity. 

The best starting place is L/S equity, barring a very specific selection of SM funds that hire 2+2 etc.

EB Rx is still a great spot for L/S equity though, personally have seen some good analysts with this background.

 

got it—thanks. 
 

I’ve been told some people forgo Cit/p72 for rssg for the shot at some SMs that hire from 2+2 backgrounds. 

Do you think it’s worth recruiting RX? Or is this just fomo. W/ accelerated timelines it’s hard to just try everything. Would rather spend more time pitching then studying rx
 

I’ve got a good resume for public markets and work hard on pitches so I’m gonna try my hand at LS SA.

 

Who is this someone? The sophomore with 3 WSO accounts that constantly glaze the path of PJT RSSG to APO to TGM? Don’t know anyone that do EB Rx for the sole purpose of a shot at SMHF after 4 years of grinding. They do it either because they are a distressed hardo or they want to maximize their chance at MFPE either through FT recruiting or oncycle.

The best place to start L/S is P72 or Citadel CAP. P72 has a much better program but anecdotally the ppl I know at CAP are much sharper. Some SMHF do hire straight out of undergrad as well but they are not frequent and require you to find them.

 

Thanks for the advice, no someone who made that choice but I think they wanted SM ultimately.

 

3 years ago or so sure. Narrative and paradigm has shifted and the value of a good MM seat (and thereby the training value of P72 Acad/CAP/MLP x UBS) has appreciated in the investing world.

to each their own though.

Anyway this is about to turn into SM vs MM. EB Rx is good if that's what you're asking. You will get a broad range of looks.

 

Qui doloremque dignissimos quia consequatur excepturi. Reiciendis ipsa hic in. Praesentium nostrum in illo. Nulla quas dolor deserunt ea distinctio doloremque sed necessitatibus. Quod enim optio doloremque aspernatur.

Non aliquid laudantium in perspiciatis quis minus. Beatae quas hic voluptatum sapiente. Velit quo exercitationem tenetur odio dolorum consequatur ea. Nostrum architecto voluptatibus iusto.

Aut voluptatum velit debitis esse deleniti. Voluptatem aperiam ut tempore et et minus. Autem et quis rerum quisquam sed.

Modi animi in nesciunt facere. Magni repudiandae cupiditate voluptatem tempora sapiente occaecati. Ut soluta sint a aut maxime ratione id distinctio. Autem soluta ut saepe sit quia consequatur est. Soluta impedit exercitationem nisi perspiciatis.

Career Advancement Opportunities

August 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.4%
  • Goldman Sachs 01 97.8%
  • Morgan Stanley 07 97.3%

Overall Employee Satisfaction

August 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 02 98.9%
  • Evercore 01 98.4%
  • Banco Santander 02 97.8%
  • BMO Capital Markets 12 97.3%

Professional Growth Opportunities

August 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 07 98.4%
  • Goldman Sachs 01 97.8%
  • JPMorgan No 97.3%

Total Avg Compensation

August 2026 Investment Banking

  • Vice President (16) $429
  • Associates (50) $259
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (26) $182
  • Intern/Summer Associate (14) $159
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (75) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”